References
- Biomarkers Definitions Working Group. Biomarkers and surrogate end points: preferred definitions and conceptual framework. Clin. Pharmacol. Ther.69(3) , 89–95 (2001).
- Rolan P , AtkinsonAJ Jr, Lesko LJ; Scientific Organizing Committee; Conference Report Committee. Use of biomarkers from drug discovery through clinical practice: report of the Ninth European Federation of Pharmaceutical Sciences Conference on Optimizing Drug Development. Clin. Pharmacol. Ther.73(4) , 284–291 (2003).
- Woolf CJ . Overcoming obstacles to developing new analgesics. Nat. Med.16(11) , 1241–1247 (2010).
- Nicholson JK , HolmesE. Global systems biology and personalized healthcare solutions. Discov. Med.6(32) , 63–70 (2006).
- Backonja M , WoolfCJ. Future directions in neuropathic pain therapy: closing the translational loop. Oncologist15(Suppl. 2) , S24–S29 (2010).
- Langley CK , AzizQ, BountraC et al. Volunteer studies in pain research – opportunities and challenges to replace animal experiments: the report and recommendations of a Focus on Alternatives workshop. Neuroimage 42(2) , 467–473 (2008).
- Breivik H , BorchgrevinkPC, AllenSM et al. Assessment of pain. Br. J. Anaesth. 101(1) , 17–24 (2008).
- Drendel AL , KellyBT, AliS. Pain assessment for children: overcoming challenges and optimizing care. Pediatr. Emerg. Care27(8) , 773–781 (2011).
- Rolke R , BaronR, MaierC et al. Quantitative sensory testing in the German research network on neuropathic pain (DFNS): standardized protocol and reference values. Pain 123 , 231–243 (2006).
- Maier C , BaronR, TölleTR et al. Quantitative sensory testing in the German research network on neuropathic pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain 150 , 439–450 (2010).
- Wilder-Smith OHG . Chronic pain and surgery: a review of new insights from sensory testing. J. Pain Palliat. Care Pharmacother.25 , 146–159 (2011).
- Seifert F , MaihöfnerC. Functional and structural imaging of pain-induced neuroplasticity. Curr. Opin Anaesthesiol.24(5) , 515–523 (2011).
- Tracey I , MantyhPW. The cerebral signature for pain perception and its modulation. Neuron55 , 377–391 (2007).
- Apkarian AV , BushnellMC, TreedeRD, ZubietaJK. Human brain mechanisms of pain perception and regulation in health and disease. Eur. J. Pain9(4) , 463–484 (2005).
- Alexander AL , LeeJE, LazarM, FieldAS. Diffusion tensor imaging of the brain. Neurotherapeutics4 , 316–329 (2007).
- Borsook D , BecerraL, HargreavesR. Biomarkers for chronic pain and analgesia. Part 2: how, where, and what to look for using functional imaging. Discov. Med.11(58) , 209–219 (2011).
- Gomez-Mancilla B , MarrerE, KehrenJ et al. Central nervous system drug development: an integrative biomarker approach toward individualized medicine. NeuroRx 2 , 683–695 (2005).
- Urban L , NagyI, LukacsK, SanthaP. Biomarkers in pain. In: Emerging Strategies for the Treatment of Chronic Pain. Campbell JN, Basbaum AJ, Dray A, Dubner R, Dworkin RH, Sang CN (Eds). IASP Press, WA, USA, 457–473 (2006).
- Ramautar R , van der Plas AA, Nevedomskaya E et al. Explorative analysis of urine by capillary electrophoresis-mass spectrometry in chronic patients with complex regional pain syndrome. J. Proteome Res.8(12) , 5559–5567 (2009).
- Abu-Asab MS , ChaouchiM, AlesciS et al. Biomarkers in the age of omics: time for a systems biology approach. OMICS 15(3) , 105–112 (2011).